The document discusses salivary gland disorders. It begins with definitions and classifications of salivary glands. It then discusses the anatomy, functions, and disorders of the parotid, submandibular, and sublingual salivary glands. Diagnostic aids are outlined including clinical history, physical examination, imaging such as CT, MRI, ultrasound and sialography. Cystic conditions of the minor salivary glands such as mucoceles are also summarized. Disorders are classified and inflammatory, obstructive, neoplastic and other conditions are described.
Multiple Submandibular Duct Calculi: A Case Reportclinicsoncology
Salivary gland calculi account for the most common disease of the salivary glands. The majority of sialoliths occur in the submandibular gland or its duct and are a common cause of acute and chronic infections. Sialolith can be unilateral, bilateral, single or multiple.
Multiple Submandibular Duct Calculi: A Case Reportpateldrona
Salivary gland calculi account for the most common disease of the salivary glands. The majority of sialoliths occur in the submandibular gland or its duct and are a common cause of acute and chronic infections. Sialolith can be unilateral, bilateral, single or multiple.
Multiple Submandibular Duct Calculi: A Case ReportSarkarRenon
Salivary gland calculi account for the most common disease of the salivary glands. The majority of sialoliths occur in the submandibular gland or its duct and are a common cause of acute and chronic infections. Sialolith can be unilateral, bilateral, single or multiple.
Salivary gland calculi account for the most common disease of the salivary glands. The majority of sialoliths occur in the submandibular gland or its duct and are a common cause of acute and chronic infections.
Multiple Submandibular Duct Calculi: A Case ReportAnonIshanvi
Salivary gland calculi account for the most common disease of the salivary glands. The majority of sialoliths occur in the submandibular gland or its duct and are a common cause of acute and chronic infections. Sialolith can be unilateral, bilateral, single or multiple. Depending on the gland affected and stone...
Multiple Submandibular Duct Calculi: A Case Reportgeorgemarini
Salivary gland calculi account for the most common disease of the salivary glands. The majority of sialoliths occur in the submandibular gland or its duct and are a common cause of acute and chronic infections. Sialolith can be unilateral, bilateral, single or multiple.
“Multiple unilateral submandibular duct calculi: A case report”.navasreni
Sialolithiasis, the formation of calcific concretions in the salivary
duct of a major or minor salivary gland, is a common salivary
gland pathology. These calcifications usually develop in the ductal system of the submandibular salivary gland, but can involve
the parotid gland and, infrequently the ducts of sublingual or minor salivary glands. 1 The size of salivary calculi may vary from
less than 1 mm to a few centimeters in size, with most cases being
less than 10 mm in size.2 Although large and multiple sialoliths
have been reported in the salivary glands, they have been rarely
reported in the salivary duct.2 Here we are reporting a case of
multiple Wharton duct sialolithiasis.
Multiple Submandibular Duct Calculi: A Case Reporteshaasini
Sialolithiasis, the formation of calcific concretions in the salivary
duct of a major or minor salivary gland, is a common salivary
gland pathology. These calcifications usually develop in the ductal system of the submandibular salivary gland, but can involve
the parotid gland and, infrequently the ducts of sublingual or minor salivary glands. 1 The size of salivary calculi may vary from
less than 1 mm to a few centimeters in size, with most cases being
less than 10 mm in size.2 Although large and multiple sialoliths
have been reported in the salivary glands, they have been rarely
reported in the salivary duct.2 Here we are reporting a case of
multiple Wharton duct sialolithiasis
Multiple Submandibular Duct Calculi: A Case Reportkomalicarol
Sialolithiasis, the formation of calcific concretions in the salivary
duct of a major or minor salivary gland, is a common salivary
gland pathology. These calcifications usually develop in the ductal system of the submandibular salivary gland, but can involve
the parotid gland and, infrequently the ducts of sublingual or minor salivary glands. 1 The size of salivary calculi may vary from
less than 1 mm to a few centimeters in size, with most cases being
less than 10 mm in size.2 Although large and multiple sialoliths
have been reported in the salivary glands, they have been rarely
reported in the salivary duct.2 Here we are reporting a case of
multiple Wharton duct sialolithiasis.
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and
offering a wide range of dental certified courses in different formats.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
2. Definition: exocrine glands secreting saliva.
Classifications:
According to size:
Major SG
Minor SG
• Parotid gland.
• 600-1000 minor SG.
• Submandibular
SG
• 1- 5 mm in diameter.
• Sublingual SG
• Each gland has a single duct.
• Present all over the oral cavity and oropharynx except:
1. Ant 1/3 of the palate.
2. Ant 1/3 of the dorsum of the tongue.
1. Attached gingiva.
3. SALIVA
Saliva contain electrolytes as Na+
, K+
, Cl, Bicarbonate, Ca+
, Phosphate,
magnesium, urea, ammonia, uric acid, glucose and cholesterol.
The electrolytes composition/ concentration in saliva secreted from the
parotid G. is higher than that of the submandibular G. except Ca+
.
Calcium concentration in the submandibular G is double that of the
parotid G Õ an important factor considering the salivary stone.
Functions:
Digestion - Serous - Ptyalin (a-amylase- hydrolysis of starch)
Lubrication › Mucus secretions (mucin = glycoprotein) - lubricant.
Antimicrobial.
5. PAROTID GLAND SUBMANDIBULAR
GLAND
SUBLINGUAL GLAND
Size Largest intermediate Smallest major SG
Parts • Superficial part.
• Deep part.
• Accessory part
(20% of
individuals): above
stensen's duct and
opens into it.
• Superficial part:
Superficial to
mylohyoid Hilum:
behind mylohyoid
ms
• Deep part: deep to
mylohyoid ms Just
beneath the floor of
the mouth
Location Retromandibular
fossa
(between ramus and
sternomastoid
muscle)
• Superficial part:
submandibular
(digastric) triangle
Deep part: sublingual
space.
Sublingual space
6. PAROTID GLAND SUBMANDIBULAR GLAND SUBLINGUAL GLAND
Duct Stensen's duct opens
in parotid papillae
opposite to upper 7.
Wharton's duct opens
in S.L caruncle.
Ducts of rivinus (8- 20
ducts) opens
Into:
a.Bartholin's duct
b.plica sublingualis
Bartholin's duct: opens
into wharton's duct or
in the floor of the
mouth.
Secretions Serous Mucus Mixed
Structures
within
External carotid A
Retromandibular Vein
Facial Nerve
7. PAROTID GLAND SUBMANDIBULAR
GLAND
SUBLINGUAL GLAND
Blood supply • Arterial
Branches of Ext.
Carotid A
• Venous
Into Ext. Jugular Vein
• Arteries
Branches of facial and
lingual arteries
• Veins
Drains to the
corresponding veins
• Arterial from
sublingual and
submental arteries
• Venous drainage
corresponds to the
arteries
Nerve in
close relation
• Marginal
mandibular N.
• Hypoglossal N.
• Lingual N.
Lingual N.
9. I. Clinical history
A. PAST AND PRESENT MEDICAL HISTORY
To determine any medical conditions or medications that is known to be
associated with salivary gland dysfunction.
Examples: patient who received radiotherapy for a head and neck
malignancy or patient who taking a tricyclic antidepressant.
These two examples associated with salivary hypofunction.
10. I. Clinical history
B. SWELLING
Intermittent swelling
If associated with eating, it suggests an obstruction and the swelling will subside between
meals if the gland is not infected.
Persistent swelling
Caused by tumors or a generalized process such as sjeogren’s syndrome, diabetes,
alcoholism…. etc.
Unilateral swelling
Results from localized processes such as infections, tumors or mechanical obstruction.
Bilateral swelling
Associated with a systemic condition such as mumps or an endocrine dysfunction.
11. I. Clinical history
C. PAIN
Pain and fullness of the gland, related only to eating suggest
obstruction.
Infection and inflammation produce a more persistent pain not related
to eating.
12. I. Clinical history
D. SALIVARY FLOW
1. Xerostomia
Commonly caused by:
Drugs.
Systemic diseases (Sjeogren’s syndrome).
Secondary to radiation therapy.
2. Sialorrhea (increased salivation)
Commonly caused by:
Secondary to an inability to swallow normal secretions.
Emotional or psychogenic factors.
Chronic neurological disorders (Parkinson’s disease, cerebral palsy, mental
retardation ... etc.)
13. II. Physical examination
A. INSPECTION
1) Size
Diffuse enlargement of a single gland suggests inflammatory process or
a tumor.
Enlargement of multiple glands suggests:
Sjeogren’s syndrome.
Metabolic disorder (alcoholic cirrhosis).
14. II. Physical examination
A. INSPECTION
2) Site.
In the preauricular and Submandibular regions parenchymal glandular
involvement must be distinguished from regional lymph node involvement.
Intra-oral minor salivary gland lesions usually appear on the posterior palate.
3) Shape.
4) Symmetry.
5) Overlying skin / mucosa.
6) Surrounding edge → well/ ill defined.
7) Inspection of the duct orifices for pus or calculus.
15. II. Physical examination
B. PALPATIONS
Palpation of the gland
Parotid gland: E.0 Bidigital palpation.
Submandibular S. G: bimanual palpation I.0 and E. 0 (submd L.N felt
E.0 only while S.Md S. G swelling felt E0 and I0)
Sublingual S.G: I.O only.
16. II. Physical examination
B. PALPATIONS
Palpation for:
Gland
Consistency.
Massaging the gland and looking at the duct orifice → duct purulence & flow of
saliva.
Duct
Palpable stone, Site, size.
17. II. Physical examination
CHECK THE INTEGRITY OF THE NERVES:
Facial nerve assessment (suspicious malignancy in parotid)
Temporal branch → ask the patient to elevate his eyebrows.
Zygomatic branch→ ask the patient to close his eye tightly.
Buccal branch → ask the patient to whistle.
Marginal mandibular branch-ask patient to smile and show his teeth
Lingual nerve assessment → test sensation of ant 2/3 of tongue.
Hypoglossal nerve assessment → check tongue movement.
Any defect of nerve function → malignant infiltration of the nerve.
18. III. Preoperative diagnostic screening
1. PLAIN RADIOGRAPHS:
Advantages:
Used to demonstrate the presence of calculi.
Used as comparative documentation after removal of the stone.
Disadvantages:
No information about ductal system and soft tissue.
1- Occlusal view
It is used for detection of calculi in the floor of mouth (Wharton’s duct).
2- Periapical film
Detect a stone in the parotid duct by placement against the inside of the cheek.
3- Puffed cheek view
For calculi of the parotid duct.
1. PLAIN RADIOGRAPHS:
Advantages:
Used to demonstrate the presence of calculi.
Used as comparative documentation after removal of the stone.
Disadvantages:
No information about ductal system and soft tissue.
1- Occlusal view
It is used for detection of calculi in the floor of mouth (Wharton’s duct).
2- Periapical film
Detect a stone in the parotid duct by placement against the inside of the cheek.
3- Puffed cheek view
For calculi of the parotid duct.
19. III. Preoperative diagnostic screening
2. COMPUTERIZED TOMOGRAPHY (CT) SCANNING:
Indication
The best choice for examination of masses of the salivary glands.
Study the diffuse non-inflammatory enlargement of the salivary glands.
3. MAGNETIC RESONANCE IMAGING (MRI):
Equal or better than CT in:
No contrast medium.
Less radiation.
No need for ductal cannulation.
Can be used in acute inflammation.
Detection of a lesion or mass.
20. III. Preoperative diagnostic screening
4. RADIONUCLIDE SCANS (SCINTIGRAPHY):
Radioactive isotope as technetium 99 is injected and traced by gamma camera.
Uptake of the isotope by the gland increase in case of acute inflammation and
decrease in case of chronic inflammation.
Indication:
Determination of space occupying lesions
Evaluate the salivary function of the glands.
Evaluation of patients when sialography is contraindicated or cannot be
performed (such as in cases of acute gland infection or iodine allergy).
21. III. Preoperative diagnostic screening
5. ULTRASONOGRAPHY:
Advantages:
Fast.
Economical.
Non-invasive.
Simple.
Indication:
Detect stone ≥ 2mm.
Detecting space occupying lesions.
Differentiate a cystic lesion from a solid mass.
Differentiate intrinsic lesion from extrinsic mass.
22. III. Preoperative diagnostic screening
6. BIOPSY
Helpful in the diagnosis of Sjeogren’s syndrome.
The most common suggested procedures are:
Excision biopsy → should be done if the diagnosis remains inconclusive after the
investigation → from the intra-oral minor salivary gland (lower lip).
Incisional biopsy → should not be done because it will seed tumor cells into the
surrounding tissues.
Fine needle aspiration biopsy (FNAB).
23. III. Preoperative diagnostic screening
7. LABORATORY INVESTIGATION:
Laboratory blood studies are helpful in the evaluation of dry mouth, particularly in
suspected cases of Sjögren’s syndrome.
The presence of nonspecific markers of autoimmunity, such as antinuclear
antibodies, rheumatoid factors, elevated immunoglobulins, and erythrocyte
sedimentation rate → the definitive diagnosis of Sjögren’s syndrome.
↑ Serum amylase → salivary gland inflammation.
24. III. Preoperative diagnostic screening
8. SIALOGRAPHY:
Definition:
Sialography is the radiographic visualization of the salivary gland following retrograde
instillation of soluble contrast material into the ducts.
Contrast medium: (both contains high percentage of iodine)
Oil based Water soluble
• High viscosity.
• Difficult to inject discomfort.
• Long time for elimination.
• E.g. lipiadol.
• Low viscosity.
• Easy to inject discomfort
• Shorter elimination time.
• E.g. (Hypaque and renografin).
25. III. Preoperative diagnostic screening
8. SIALOGRAPHY:
Appearance
The normal ductal architecture has a “leafless tree” appearance.
Non-opaque sialoliths appear as voids.
Sialectasis is the appearance of focal collections of contrast medium within the
gland, seen in cases of sialadenitis and Sjögren’s syndrome.
Indications:
Detection of ductal obstruction, stenosis &stricture
The presence and the size of the tumors
Detection of salivary fistula
26. III. Preoperative diagnostic screening
8. SIALOGRAPHY:
Therapeutics uses:
CM contains Iodine (bacteriostatic effect).
Drainage of ductal debris & mucus plug.
28. III. Preoperative diagnostic screening
8. SIALOGRAPHY:
Advantages
Detection of radiolucent sialoliths.
Functional evaluation of the gland.
Detection of the position and size of a neoplasm.
Fistulae and abscess cavities can be displayed.
Disadvantages:
Invasive.
Requires iodine dye.
29. III. Preoperative diagnostic screening
9. SIALOENDOSCOPE
Indications:
Diagnosis of S.G pathosis either in duct or parenchyma.
Used to dilate small stricture.
Limitations:
Acute infection (Painful and may perforate the duct lumen).
Too narrow duct.
30. III. Preoperative diagnostic screening
10. SIALOCHEMISTRY:
Saliva can be collected from the parotid and Submandibular glands by cannulation
of their ducts.
If ↑ Na+
and ↓K+
Ô Sialadenitis.
The saliva can be analyzed for:
Electrolytes (Sodium, potassium, chloride, phosphate).
Flow rate.
Total salivary proteins (Amylase, glycoprotein, and albumin).
Immunoglobulin.
36. I. CYSTIC CONDITIONS
MINOR SALIVARY GLANDS
THE MUCOCELE
Swelling caused by the accumulation of saliva at the site of a traumatized or
obstructed minor salivary gland duct.
Classified into:
Extravasation Mucocele: traumatic injury → salivary leakage into the surrounding
tissue → granulation tissue “encapsulation”
Retention Mucocele: Represents dilatation of salivary excretory duct due to
obstruction by a mucous plug or sialolith formation (FOM, palate)
The site: the lower lip in young people, buccal mucosa.
37. I. CYSTIC CONDITIONS
MINOR SALIVARY GLANDS
THE MUCOCELE
Etiology: minor trauma.
Clinically:
Superficial lesion: small bluish translucent, smooth, fluctuant vesicle.
Deep lesion: a firmer vesicle with the same color of normal mucosa.
Diagnosis
History of painless swelling
Clinical examination: fluctuant swelling mainly in lower lip
X-ray –ve.
Aspiration → mucus.
38. I. CYSTIC CONDITIONS
MINOR SALIVARY GLANDS
THE MUCOCELE
Treatment:
Simple removal of the “cyst” leads to recurrence of the mucocele 15-30%.
A vertical incision over the lesion with removal of the underlying minor salivary
gland.
In recurrent cases, a CO2 laser is used.
39. I. CYSTIC CONDITIONS
SUBLINGUAL GLAND
THE RANULA
It’s the accumulation of saliva beneath the thin mucous membrane of the floor of
the mouth due to obliteration of sublingual gland duct.
Clinically:
Soft, compressible, painless bluish mass enlarge slowly.
May raise the tongue and interfere with the speech.
Etiology: Extravasations of saliva secondary to trauma.
40. I. CYSTIC CONDITIONS
SUBLINGUAL GLAND
THE RANULA
“Plunging” ranula:
The mylohyoid muscle does not always form a complete diaphragm for the floor
of the mouth, and leakage of saliva below the mylohyoid can allow the lesion to
present in the upper neck.
Diagnosis
History of painless swelling
Clinical examination: fluctuant swelling at one side of floor of mouth or cervical
ranula
X-ray –ve.
Aspiration → mucus.
42. II. INFLAMMATORY/REACTIVE
CONDITIONS
A. NON-SPECIFIC
1. ACUTE BACTERIAL (SUPPURATIVE) SIALADENITIS
(POSTSURGICAL PAROTITIS)
• A suppurative process affecting the major glands more often than the minor glands.
• More common in parotid
Predilection for Parotid:
1. The parotid is more prone to bacterial infection due to its secretions are serous and thus lack the protective
constituents (IgA, lysozomes) seen in mucinous secretions of the other salivary glands.
2. The submandibular glands may be protected by the high level of mucin in the saliva, which has potent antimicrobial
activity.
43. II. INFLAMMATORY/REACTIVE
CONDITIONS
A. NON-SPECIFIC
1. ACUTE BACTERIAL (SUPPURATIVE) SIALADENITIS
(POSTSURGICAL PAROTITIS)
Etiology
1.Salivary stasis → retrograde contamination of the salivary ducto-acinar units by oral flora (Bacterial ascending
infection).
2.Causes of salivary stasis include postsurgical setting, dehydration, medical illness, radiation, aging and sialolithiasis.
3.Postoperative sialadenitis is due to decrease in salivary flow during anesthesia + administration of anticholinergic
drugs.
44. II. INFLAMMATORY/REACTIVE
CONDITIONS
A. NON-SPECIFIC
1. ACUTE BACTERIAL (SUPPURATIVE) SIALADENITIS
(POSTSURGICAL PAROTITIS)
Clinical presentation
1.General symptoms; fever….
2.Sudden onset of unilateral or bilateral salivary gland enlargement.
3.The involved gland is painful, indurated, and tender to palpation.
4.The overlying skin may be erythematous.
5.Purulent discharge from Stensen’s duct
45. II. INFLAMMATORY/REACTIVE
CONDITIONS
A. NON-SPECIFIC
1. ACUTE BACTERIAL (SUPPURATIVE) SIALADENITIS
(POSTSURGICAL PAROTITIS)
Diagnosis:
1.History: swelling and pain
2.Clinical examination
• E.0 examination → Redness, hotness, tenderness, and swelling. Fistulous tract.
• IO examination → Pus oozing through duct on milking the gland.
3.Imaging: CT, MRI, Ultrasound and scintigraphy
4.Needle aspiration → pus.
46. II. INFLAMMATORY/REACTIVE
CONDITIONS
A. NON-SPECIFIC
1. ACUTE BACTERIAL (SUPPURATIVE) SIALADENITIS (POSTSURGICAL PAROTITIS)
Treatment of Acute Sialadenitis/Parotitis
1.Culture and sensitivity testing (for appropriate antibiotics).
2.Supportive measures
Fluid replacement.
Empirical antibiotic and analgesics.
Improved oral hygiene.
Massage of the gland.
Warm compresses.
Sialogogues (salivary stimulants).
3. Failure to respond → incision and drainage.
4. Incisions should be placed parallel to facial nerve branches to avoid injury.
47. II. INFLAMMATORY/REACTIVE
CONDITIONS
A. NON-SPECIFIC
1. ACUTE BACTERIAL (SUPPURATIVE) SIALADENITIS
(POSTSURGICAL PAROTITIS)
Complications of Acute Parotitis
1.Direct extension.
Into external auditory canal and TMJ.
Into the parapharyngeal space → airway obstruction, mediastinitis, internal jugular thrombosis and carotid artery
erosion.
3. Hematogenous spread
4. Dysfunction of one or more branches of the facial nerve.
48. II. INFLAMMATORY/REACTIVE
CONDITIONS
A. NON-SPECIFIC
2. NECROTIZING SIALOMETAPLASIA
• Benign self-limiting condition of the oral cavity.
• It originates from the minor salivary glands of the hard palate, buccal mucosa, lip
or retro molar area.
49. II. INFLAMMATORY/REACTIVE
CONDITIONS
A. NON-SPECIFIC
2. NECROTIZING SIALOMETAPLASIA
Clinical picture:
Presents as an ulcer.
It is usually painless.
The ulcer may be unilateral or bilateral and appears large, deep
and sharply demarcated.
Etiology: Local ischemia (trauma, L.A injury, smoking).
Treatment: Self-limiting & heals by secondary intention in 6-8 weeks.
50. II. INFLAMMATORY/REACTIVE
CONDITIONS
B. SPECIFIC INFLAMMATION
Non-suppurative bilateral acute sialadenitis of viral origin.
It is a contagious disease (Droplet infection).
Its incubation period is 2-3 weeks.
It affects mostly children at 6-8 years old.
Mumps (epidemic parotitis)
51. II. INFLAMMATORY/REACTIVE
CONDITIONS
B. SPECIFIC INFLAMMATION
Mumps (epidemic parotitis)
The causative virus
1.Mumps paramyxovirus.
2.Coxsackie virus A.
3.Echo virus.
Clinical picture:
1.Painful parotid swelling may last 2 weeks.
2.Usually one gland is affected first then the other.
3.The symptoms subside in 3-7 days and recovery occurs within 2-3 weeks.
52. II. INFLAMMATORY/REACTIVE
CONDITIONS
B. SPECIFIC INFLAMMATION
Mumps (epidemic parotitis)
Complications of mumps:
1.Other organs (e.g., testes, ovaries, breasts, and pancreas) may be affected.
2.In adults, orchitis may lead to sterility.
Diagnosis:
1.Leucocytopeniawith relative lymphcytosis.
2.Increase in serum amylase (normal by 2-3w of disease).
3.Serology reveals:
•Complement fixing antibodies.
•S or soluble antibodies.
53. II. INFLAMMATORY/REACTIVE
CONDITIONS
B. SPECIFIC INFLAMMATION
Mumps (epidemic parotitis)
Treatment
1. It resolves spontaneously in 5-10 days.
2. Symptomatic relief of pain and fever (analgesic antipyretic).
3. Prevention of dehydration is essential by increase fluid uptake.
54. III. IMMUNOLOGIC DISORDERS
SJEOGREN’S SYNDROME
DEFINITION
Sjögren’s syndrome is an autoimmune disease characterized primarily by
decreased lacrimal and salivary gland secretions.
CLINICAL FEATURES:
Triad of:
1.Xerostomia (mouth).
2.Keratoconunctivitis sicca (eyes).
3.A connective tissue disease (usually rheumatoid arthritis).
Salivary, mucous and lacrimal glands replacement by a lymphocytic infiltrate
causes the classic symptoms of dry eyes, dry mouth and parotid swelling.
55. TWO FORMS:
Primary: involves the exocrine glands only
Secondary: associated with a definable autoimmune disease, usually rheumatoid
arthritis.
DIAGNOSIS
Diagnostic tests include:
Schirmer’s tear function
Using two strips of red litmus papers placed at the inner side of the lower eyelid
(area of lacrimal glands). A positive finding is lacrimation of 5 mm.
Sialography will give “the apple-tree in blossom” appearance.
Salivary biopsy (either from the lower lip or the tail of the parotid gland.
Immunologic and hematologic laboratory studies.
56. TREATMENT
Dry foods, smoking and alcohol consumption should be avoided.
Treatment is directed to:
Supportive care with sialogauges to stimulate salivation and salivary
replacement by means of methylcellulose.
Supportive care with artificial tears.
Treatment of the autoimmune connective tissue diseases.
57. IV. OBSTRUCTIVE DISORDERS
SIALOLITHIASIS
DEFINITION
The formation of calcific masses (stones) within the ductal system of a major or minor
salivary gland.
CAUSES OF OBSTRUCTION INCLUDE
Salivary calculi (Sialolithiasis).
Pressure on the duct due to an adjacent mass.
Invasion of the duct by a malignant neoplasm.
Mucous retention/extravasation.
58. IV. OBSTRUCTIVE DISORDERS
SIALOLITHIASIS
CLINICAL FEATURES
It occurs in men twice as often as in women.
The Submandibular gland is the most common site of involvement (80%), followed
by the parotid (19%).
The stones are single, but it may be multiple (more in the parotid in this case).
ETIOLOGY
The exact nature of stone formation is not known, but may be due to:
The calculi are believed to arise from the deposition of ca ++ salt around a nidus of
debris within the duct lumen, these debris include bacteria, ductal epith cells, or
foreign bodies.
59. IV. OBSTRUCTIVE DISORDERS
SIALOLITHIASIS
FORMATION OF CALCULI IS ALSO FACILITATED BY SEVERAL
SECONDARY FACTORS:
The mucous content of the submandibular gland makes its secretions more
viscous than the parotid.
The duct of the submandibular gland is longer than that of the parotid gland
and runs against gravity in a tortous.
The submandibular duct is situated at a lower level than its orifice.
60. IV. OBSTRUCTIVE DISORDERS
SIALOLITHIASIS
SIGNS AND SYMPTOMS:
Absence of subjective symptoms (discovered accidental).
Eating initiates intermittent transient swelling accompanied by moderate
discomfort.
The involved gland is enlarged and tender.
Stasis of the saliva → infection, ductal stricture, and ductal dilatation fibrosis, and
gland atrophy.
No salivary flow or purulent discharge.
If the treatment is not beginning: Swelling, redness and tenderness are present
along the course of Wharton’s duct & pus may exude from the duct orifice.
62. IV. OBSTRUCTIVE DISORDERS
SIALOLITHIASIS
TREATMENT
Treatment Modalities
Removal of the stone:
Conservative management by:
1. Milking the gland.
2. Shock-wave Lithotripsy (external and intraductal).
3. Electrohydraulic Lithotripsy.
4. Interventional sialendoscopy
Surgical removal (Sialolithotomy).
Gland excision (Sialadenectomy).
63. IV. OBSTRUCTIVE DISORDERS
SIALOLITHIASIS
I. CONSERVATIVE MANAGEMENT
1. MILKING THE GLAND.
Stone may be removed by spontaneous exfoliation on stimulation of salivation to flush
the stone out of the duct:
Indication:
Small, mobile stone at or just behind the duct orifice.
Stone causing partial obstruction.
Procedures
Hydration.
Application of moist warm heat.
Gland massage.
The use of sialogogues.
64. IV. OBSTRUCTIVE DISORDERS
SIALOLITHIASIS
2. SHOCK-WAVE LITHOTRIPSY (EXTERNAL AND INTRADUCTAL).
3. ELECTROHYDRAULIC LITHOTRIPSY.
4. INTERVENTIONAL SIALENDOSCOPY
II.SURGICAL TREATMENT
Extraglandular → removal of the stone (sialolithotomy) → intraoral approach.
Intraglandular → removal of the gland → intraoral approach (sublingual gl) or Extraoral
approach (Parotid, submand. gl).
65. IV. OBSTRUCTIVE DISORDERS
SIALOLITHIASIS
1. STONE REMOVAL
Surgical removal of submandibular duct sialoliths (sialolithiotomy, sialodochplasty,
marsupialization or 2nd
duct orifice):
Surgical removal of parotid duct sialoliths (sialolithiotomy)
2. GLAND REMOVAL (SIALADENECTOMY):
Indication
Very posterior stones.
Intra-glandular stones.
Irreversible parenchymal damage.
68. 1- MIXED TUMOR (PLEOMORPHIC ADENOMA)
INCIDENCE AND LOCATION
Most common salivary gland tumors.
The majority arise in the parotid (84%).
Mixed tumors account for more than 50% all intra-oral minor salivary gland
tumors.
Male to female is 3:2.
5% malignant transformation.
69. 1- MIXED TUMOR (PLEOMORPHIC ADENOMA)
CLINICAL FEATURES
In the parotid gland, these neoplasms are slow growing and usually occur in the
posterior inferior aspect of the superficial lobe.
In the submandibular glands, these neoplasms are well-defined palpable masses.
Intraorally, the mixed tumor most often occurs on the palate, followed by the
upper lip and buccal mucosa.
Mobile, except when they occur in the hard palate, where they are adhering firmly
to the underlying tissue.
70. 1- MIXED TUMOR (PLEOMORPHIC ADENOMA)
TREATMENT
Complete excision with 1 cm margins of clinically uninvolved normal tissue.
For the parotid gland, superficial parotidectomy with preservation of the facial
nerve.
For the Submandibular gland, complete excision of the gland is indicated.
For intraoral tumors, extracapsular excision is indicated including the overlying
mucosa and saucerization of any bony margins of resection.
71. 2- MONOMORPHIC ADENOMA
Benign salivary gland tumors composed predominantly of epithelium with no
evidence of mesenchymal tissue.
INCIDENCE AND LOCATION
Rare tumor the parotid and minor salivary glands.
CLINICAL FEATURES
A submucosal nodular mass.
Freely mobile firm to slightly compressible.
Normal color of overlying mucosa.
TREATMENT
Extracapsular surgical excision
72. 3-WARTHIN'S TUMOR (CYSTADENOLYMPHOMA,
PAPILLARY CYSTAENOMA LYMPHATOSUM)
INCIDENCE AND LOCATION
6% of epithelial tumors of the salivary glands.
Almost in the parotid gland.
3-4% of all minor salivary gland tumors
Intraorally, most commonly in the palate and buccal mucosa.
CLINICAL FEATURES
Soft to firm, It grows slowly.
Asymptomatic mass in the parotid.
Arise from salivary gland tissue sequestered in lymph nodes.
TREATMENT
Surgical excision with safety margins and superficial parotidectomy.
74. 1- MUCOEPIDERMOID CARCINOMA
INCIDENCE AND LOCATION:
70 % in the parotid.
20 % minor salivary glands.
10 % submandibular gland.
RADIOGRAPHIC FEATURES: Multilocular radiolucency.
75. 1- MUCOEPIDERMOID CARCINOMA
CLINICAL FEATURES:
The low-grade tumor in the palate
Grow very slowly
Not ulcerated until after very long time
Appear bluish in color
Don't invade the bone
The low-grade tumor in parotid
Freely movable
Firm
Circumscribed mass
76. 1- MUCOEPIDERMOID CARCINOMA
CLINICAL FEATURES:
The high-grade tumor in the palate
Faster growing
Diffuse
Ulcerate early
Destruct underlying bone
Painful
The high-grade tumor in parotid
Diffuse mass
Fixed
Facial nerve affection
77. 1- MUCOEPIDERMOID CARCINOMA
TREATMENT
The low-grade tumor in the palate
Tumor excision with 1 cm of soft tissues margin.
The high-grade tumor in the palate
Hemimaxillectomy + postoperative radiotherapy.
Bilateral neck dissection.
78. 1- MUCOEPIDERMOID CARCINOMA
TREATMENT
The low-grade tumor in parotid
Involve superficial lobe and without facial nerve involvement→ superficial
parotidectomy + nerve preservation.
If it extends to deep lobe or involve facial nerve → total parotidectomy + nerve
resection, then nerve grafting.
The high-grade tumor in parotid
Total parotidectomy + nerve resection.
Ispilateral neck dissection + radiotherapy postoperative.
79. 2- ADENOCYSTIC CARCINOMA
INCIDENCE AND LOCATION
Most common in the palate.
Most common malignant tumor of Submandibular S.G and parotid G.
Age: 53 years.
Male to female 3:2.
CLINICAL FEATURES:
Slowly growing, non-ulcerated mass, Unilocular mass.
Firm on palpation.
Bone invasion occurs.
Lung metastasis.
Chronic dull pain.
80. 2- ADENOCYSTIC CARCINOMA
TREATMENT
Because of the ability of this lesion to spread along the nerve sheaths, radical surgical
excision of the lesion is the treatment.
1. FOR PALATE:
Hemi-maxillectomy with 3 cm safely margin
Complete extirpation of pterygomaxillary space till skull base
Extirpation of greater palatine nervous bundle to skull base
2. FOR PAROTID G:
Total parotidectomy + nerve preservation if facial nerve not involved
If it involves facial nerve → total parotidectomy + nerve resection, then nerve
grafting.
3. FOR SUMANDIBULAR S.G AND TONGUE:
Radical excision & post surgical radiotherapy and chemotherapy.